GP GETEIN BIOTECH, INC. Trademark

Trademark Overview


On Wednesday, November 17, 2021, a trademark application was filed for GP GETEIN BIOTECH, INC. with the United States Patent and Trademark Office. The USPTO has given the GP GETEIN BIOTECH, INC. trademark a serial number of 79330277. The federal status of this trademark filing is REGISTERED as of Tuesday, August 22, 2023. This trademark is owned by Getein Biotech, Inc.. The GP GETEIN BIOTECH, INC. trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Medicines for human purposes, namely, medicines for the treatment of cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; biological preparations for medical purposes, namely, prepa...

Diagnostic testing apparatus for testing blood sugar levels, cancer cells, DNA, sugars, hormones, enzymes, lipids, vitamins, inorganic ions, electrolytes, drugs and drug metabolites, autoantibodies, proteins, microorganisms, Drug allergy, allergens, antigens of pathogenic pathogens, antibodies of pathogenic pathogens and nucleic acids of pathogenic pathogens, blood type, tissue type, human genes, hereditary diseases, biochemical indicators, immune function indicators, narcotics, psychotropic drugs, Toxic drugs for medical use, therapeutic drug targets, tumor markers for medical purposes; diagnostic apparatus for use in medical analysis of blood; surgical apparatus and instruments; blood testing apparatus; galvanic therapeutic appliances for wound healing; Diagnostic apparatus for medical purposes for testing blood sugar levels, cancer cells, DNA, sugars, hormones, enzymes, lipids, vitamins, inorganic ions, electrolytes, drugs and drug metabolites, autoantibodies, proteins, microorganis...
gp getein biotech, inc.

General Information


Serial Number79330277
Word MarkGP GETEIN BIOTECH, INC.
Filing DateWednesday, November 17, 2021
Status700 - REGISTERED
Status DateTuesday, August 22, 2023
Registration Number7141193
Registration DateTuesday, August 22, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 6, 2023

Trademark Statements


Description of MarkThe mark consists of the wording "GP GETEIN BIOTECH, INC.", "GP" formed by horizontal lines and appearing to the left of "GETEIN BIOTECH, INC.".
Goods and ServicesMedicines for human purposes, namely, medicines for the treatment of cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; biological preparations for medical purposes, namely, preparations for the treatment of cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; diagnostic preparations for medical purposes; biochemical preparations for medical use, namely, preparations for the treatment of cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; Medicated serums for treatment of viral infections, diseases of the blood system, diseases of the immune system, skin diseases, diseases caused by bacterial exotoxins, bacterial infections, fungal infections, parasitic infections; chemical preparations for medical purposes, namely, for cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; Drugs for medical purposes for the treatment of cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; Pharmaceutical preparations for the treatment of cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases; vaccines; dietetic substances adapted for medical use
Translation of Words in MarkThe wording "GETEIN" has no meaning in a foreign language.
Goods and ServicesDiagnostic testing apparatus for testing blood sugar levels, cancer cells, DNA, sugars, hormones, enzymes, lipids, vitamins, inorganic ions, electrolytes, drugs and drug metabolites, autoantibodies, proteins, microorganisms, Drug allergy, allergens, antigens of pathogenic pathogens, antibodies of pathogenic pathogens and nucleic acids of pathogenic pathogens, blood type, tissue type, human genes, hereditary diseases, biochemical indicators, immune function indicators, narcotics, psychotropic drugs, Toxic drugs for medical use, therapeutic drug targets, tumor markers for medical purposes; diagnostic apparatus for use in medical analysis of blood; surgical apparatus and instruments; blood testing apparatus; galvanic therapeutic appliances for wound healing; Diagnostic apparatus for medical purposes for testing blood sugar levels, cancer cells, DNA, sugars, hormones, enzymes, lipids, vitamins, inorganic ions, electrolytes, drugs and drug metabolites, autoantibodies, proteins, microorganisms, Drug allergy, allergens, antigens of pathogenic pathogens, antibodies of pathogenic pathogens and nucleic acids of pathogenic pathogens, blood type, tissue type, human genes, hereditary diseases, biochemical indicators, immune function indicators, narcotics, psychotropic drugs, Toxic drugs for medical use, therapeutic drug targets, tumor markers; Medical apparatus and instruments, namely, for cardiovascular diseases, cardiovascular and cerebrovascular diseases, cancer, infectious diseases, heart diseases, respiratory diseases, immune system diseases, kidney diseases, gastrointestinal diseases, diabetes, coagulation abnormalities, blood system diseases, liver diseases, tumor, trace element deficiency, allergic disease, genetic disease, gonadal disease, hormone disorder, venereal disease, thyroid disease, bone disease, metabolic disease, pancreatic disease, inflammatory disease, inorganic ion abnormality, electrolyte abnormality, hand-foot-mouth disease, specific protein abnormalities, pregnancy diseases, rheumatic diseases, digestive system diseases, urinary system diseases, reproductive system diseases, endocrine diseases, musculoskeletal diseases, sexual dysfunction, neurological diseases, ophthalmic diseases, skin diseases, psychiatric diseases diagnosis; urological apparatus and instruments for surgery, diagnostic testing, treatment, adjuvant therapy; X-ray apparatus for medical purposes
Disclaimer with Predetermined Text"BIOTECH, INC."

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 4, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, May 4, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGetein Biotech, Inc.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCN

Party NameGetein Biotech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN

Party NameGetein Biotech, Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Monday, December 11, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, November 22, 2023FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, November 22, 2023FINAL DISPOSITION PROCESSED
Wednesday, November 22, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 22, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 22, 2023REGISTERED-PRINCIPAL REGISTER
Sunday, June 25, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, June 7, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 7, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, June 6, 2023NOTIFICATION PROCESSED BY IB
Tuesday, June 6, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 6, 2023PUBLISHED FOR OPPOSITION
Wednesday, May 17, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 17, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 17, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 4, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 4, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, May 4, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, May 4, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, May 4, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, April 27, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 27, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 21, 2022REFUSAL PROCESSED BY IB
Thursday, November 3, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, November 3, 2022REFUSAL PROCESSED BY MPU
Saturday, September 10, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, September 9, 2022NON-FINAL ACTION WRITTEN
Monday, August 29, 2022ASSIGNED TO EXAMINER
Tuesday, January 11, 2022APPLICATION FILING RECEIPT MAILED
Friday, January 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 6, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB